Genomma Lab Internacional Performance
| GNMLFDelisted Stock | USD 1.14 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.13, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Genomma Lab's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genomma Lab is expected to be smaller as well. Genomma Lab Internacional right now retains a risk of 0.0%. Please check out Genomma Lab variance, skewness, as well as the relationship between the Skewness and day typical price , to decide if Genomma Lab will be following its current trending patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Genomma Lab Internacional has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Genomma Lab is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 2.1 B | |
| Total Cashflows From Investing Activities | -765.6 M |
Genomma |
Genomma Lab Relative Risk vs. Return Landscape
If you would invest 114.00 in Genomma Lab Internacional on October 24, 2025 and sell it today you would earn a total of 0.00 from holding Genomma Lab Internacional or generate 0.0% return on investment over 90 days. Genomma Lab Internacional is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Genomma, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Genomma Lab Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genomma Lab's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Genomma Lab Internacional, and traders can use it to determine the average amount a Genomma Lab's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GNMLF |
Based on monthly moving average Genomma Lab is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genomma Lab by adding Genomma Lab to a well-diversified portfolio.
Genomma Lab Fundamentals Growth
Genomma Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Genomma Lab, and Genomma Lab fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genomma Pink Sheet performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 1.09 B | |||
| Shares Outstanding | 1 B | |||
| Price To Earning | 11.09 X | |||
| Price To Book | 1.38 X | |||
| Price To Sales | 0.05 X | |||
| Revenue | 15.49 B | |||
| EBITDA | 2.84 B | |||
| Cash And Equivalents | 1.3 B | |||
| Cash Per Share | 1.30 X | |||
| Total Debt | 3.83 B | |||
| Debt To Equity | 0.51 % | |||
| Book Value Per Share | 10.98 X | |||
| Cash Flow From Operations | 1.47 B | |||
| Earnings Per Share | 0.07 X | |||
| Total Asset | 21.54 B | |||
About Genomma Lab Performance
By analyzing Genomma Lab's fundamental ratios, stakeholders can gain valuable insights into Genomma Lab's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Genomma Lab has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genomma Lab has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico. Genomma Lab operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2327 people.Things to note about Genomma Lab Internacional performance evaluation
Checking the ongoing alerts about Genomma Lab for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Genomma Lab Internacional help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genomma Lab is not yet fully synchronised with the market data | |
| Genomma Lab may become a speculative penny stock | |
| Genomma Lab has a very high chance of going through financial distress in the upcoming years | |
| About 29.0% of the company shares are held by company insiders |
- Analyzing Genomma Lab's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genomma Lab's stock is overvalued or undervalued compared to its peers.
- Examining Genomma Lab's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genomma Lab's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genomma Lab's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genomma Lab's pink sheet. These opinions can provide insight into Genomma Lab's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Genomma Pink Sheet
If you are still planning to invest in Genomma Lab Internacional check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genomma Lab's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |